Thus, in insulin‐sensitive tissues (i.e., skeletal muscle and adipose tissue), TXNIP seems to decrease the number of GLUT4 transporters on the cell surface and reduce the glucose uptake in order to prevent hypoglycemia under fasting conditions. This evidence concerns the gene SLC2A4 and Hypoglycemia.